ArticleJournal of inflammation research2025
MAP17 is a Novel NASH Progression Biomarker Associated with Macrophage Infiltration, Immunotherapy Response, and Oxidative Stress.
Zhiwei Huang et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.